Plants as bioreactors have been widely used to express efficient vaccine antigens against viral, bacterial and protozoan infections. To date, many different plant-based expression systems have been analyzed, with a growing preference for transient expression systems. Antibody expression in diverse plant species for therapeutic applications is well known, and this review provides an overview of various aspects of plant-based biopharmaceutical production. Here, we highlight conventional and gene expression technologies in plants along with some illustrative examples. In addition, the portfolio of products that are being produced and how they relate to the success of this field are discussed. Stable and transient gene expression in plants, agrofiltration and virus infection vectors are also reviewed. Further, the present report draws attention to antibody epitope prediction using computational tools, one of the crucial steps of vaccine design. Finally, regulatory issues, biosafety and public perception of this technology are also discussed.
Introduction
Currently, many types of transgenic cells are used as source material in vaccine production. When antigens are expressed in wild or engineered systems, the process to remove toxins and host proteins contribute to increase production costs [1] . Moreover, these systems are also sensitive to contamination by other microorganisms that often escape detection in pure vaccines. In response to the challenges faced by current pharmaceutical production practices, plant molecular farming has emerged as a viable technology for the production of recombinant proteins like enzymes, monoclonal antibodies (mAbs) and antigens for human and animal vaccines [2] [3] [4] . Plant expression systems have several intrinsic advantages vis-á -vis bacteria, yeast, insect or mammalian systems in terms of speed, costs, scalability and safety [5, 6] . In addition, plants have the capacity to perform posttranslational changes which are important in protein folding, trafficking, stability and biological activity [7, 8] . Plant-derived antibodies (PDAbs) have been developed for protection against different pathogens, including viruses, bacteria and fungi [9, 10] . Investigators have also analyzed plant-based expression systems with a growing preference for transient expression systems [1, 11] . There are several notable reports on stable transformation of plant nuclear and plastid genomes [12] [13] [14] . Furthermore, alternative approaches such as systems biology and gene editing have been reported for developing therapeutic products in other organisms. These studies pave the way to adopt these concepts to plant-derived antibody production [15, 16] .
In this article, we review conventional and state-of-the-art plant-based gene expression technologies along with some illustrative examples ( Figure 1 ).
The expression of antigens in plants

Stable and transient expression of antigens
During stable transformation, the foreign gene is integrated into the genome of the cell using Agrobacterium or biolistic approaches (microprojection, bombardment and protoplast transformation). However, this type of transformation has some shortcomings; Agrobacterium has target limitations and expression of desired protein with respect to total soluble plant protein is low (0.01%-0.30%) [17] . Alternatively, in transient systems, the foreign gene is expressed without being integrated into the genome [17] . Traditionally, the process of generation of stable transgenic lines is time consuming and cumbersome, whereas transient expression systems are rapid and simple.
For rapid development of vaccines, attempts were made to explore transient gene expression. Examples of the transformation of antigen genes into plant genomes are outlined in Tables 1-3. Initial studies described the production of a surface protein (spa A) from Streptococcus mutans (0.02% of total leaf protein) in tobacco plant [47] . Early attempts for vaccine production used transgenic plants for expression of LT-B (heat labile) protein (0.05% of total soluble proteins) of Escherichia coli in tobacco plant [48] (Rosales-Mendoza et al. 2011). In case of diarrhea, the enterotoxin B subunit (LTB) from E. coli and cholera toxin (CT) were expressed in chloroplast genome of tobacco, maize and rice [24, 49, 50] .
Plant virus fusion proteins
Plant viral vectors represent a promising approach for the expression of antigenic epitopes with self-assembling viral peptides, as they can mount simple and rapid infections, allowing production of large amounts of recombinant protein in susceptible hosts [51] . The widely used technique for transient transformation uses recombinant plant viruses as protein expression vectors such as potato virus X (PVX), cowpea mosaic virus (CPMV), tobacco mosaic virus (TMV) and cucumber mosaic virus. A generalized diagram of recombinant PDAbs production versus selective breeding is presented in Figure 2 . This explains how these specified methods can be pivotal toward effective PDAbs production. The CT of Vibrio cholerae has two components, CT-A and CT-B, where CT-B accounts for mucosal and serum immunity [52] . The genes for CT-B were cloned in plant expression vectors and transformed into tobacco plants [53] .
It is also feasible to express foreign proteins with viral coat protein (CP). Advantages of this 'overcoat' approach are the relative ease with which modified viral particles can be purified from infected tissues, and the drastic augmentation in its immunogenicity on presentation of numerous copies of an antigenic peptide on the surface of a macromolecule carrier [54] . The epitopes from various pathogens have been expressed in plants using various CPs from plant viruses as carriers (Table 3) . The D2 epitope of the fibronectin-binding protein B of Staphylococcus aureus was expressed with the CP of CPMV. Treatment induced both serum and mucosal antibodies against the D2 peptide. Similarly, a capsid protein from Norwalk virus was expressed in tomato [55] . In CPMV, an icosahedral viral particle with several useful properties, a CP gene was used to encode fusion recombinant antigens [56] . One more study Figure 1 . Demonstration of approaches used for the production of plantibodies. In silico tools assist in epitope prediction for antibodies to be expressed as PDAbs. The gene designed for vaccination is integrated into a vector and transferred into plant cells via suitable gene transfer approaches reported the expression of recombinant CPMV fused with human rhinovirus (HRV) as CPMV-HRV-II in cowpea leaves [57] . One example reported the expression of Norwalk virus capsid protein (NVCP) with a 35S Cauliflower mosaic virus (CaMV) promoter or a potato-specific patatin promoter in conjunction with Agrobacterium Tumefaciens. The construct was transformed into the tobacco and microtubers of potato to produce NVCP protein [58] . Furthermore, expression of the surface antigen hepatitis B virus (HbaAg) was reported in tobacco [59] , in leaves of potato [60] and in tomato [61] . In a recent study, investigators demonstrated that transformation of the Nicotiana benthamiana with RhoA peptide resulted in successful protein expression and reduced growth of respiratory syncytial virus [62] .
Nevertheless, CP fusions are not tolerated as they can obstruct particle assembly and spread [63] . This has been largely overcome by introducing the foot-and-mouth disease virus (FMDV) 2A peptide between the heterologous sequence and the CP open reading frame (ORF) (Figure 3 ). The expressed proteins were efficiently assembled into particles and encapsidated the viral RNA without any significant effect on the virus viability [63] . Having established the utility of the approach, several antigen candidates have reported rotavirus inner capsid protein (VP6) [64] , swine fever virus (SFV) E2 glycoprotein [65] , tuberculosis early secretory antigenic target (ESAT-6) protein [66] and the hepatitis C virus envelope protein R9 [67] . PVX virions carrying the Classical Swine Fever Virus (CSFV) glycoprotein epitope Tuberculosis Tuberculosis antigen Arabidopsis thaliana [28] produced an immunoprotective response in rabbits [65] , and the R9 epitope on the surface of PVX particles was highly immunogenic in mice [67] . Other pox viruses with a variety of hosts have also been used to express a foreign gene as a fusion protein with CP, separated by the FMDV 2A peptide: pepino mosaic virus infecting N. benthamiana plants [68] and Plantago asiatica mosaic virus infecting N. bethamiana and Arabidopsis thaliana [69] . The bipartite CPMV has been extensively used as a virus vector system for the expression of proteins in plants. The use of 2 A instead of viral cleavage motifs diminished the number of virus-derived amino acids linked to the expressed foreign protein, and as in PVX 'overcoat' vectors, some of the protein is present in virus particles. This approach has subsequently been used to express hepatitis B virus (HBV) nucleocapsid protein (HBcAg) [70] and small immune proteins specific for transmissible gastroenteritis virus (TGEV) [71] . In soybean-infecting bean pod mottle virus vectors, nonidentical FMDV 2A peptide sequences were used both to assist simultaneous co-expression of two dissimilar proteins and to reduce instability of the introduced genetic elements [72] . Recently, expression of synthetically stabilized virus-like particle (sVLP) for vaccine with D antigenicity of poliovirus was reported in N. benthamiana [73] .
Edible vaccines
In developing countries, vaccine costs can be a limiting factor in healthcare. A published report in Decade of Vaccines indicated that the total cost of vaccination had increased significantly from $1.37 in 2001 (to vaccinate against six diseases) to $38 in 2011 (for 11 diseases) [74] . In another study, it was reported that bacterial and viral antigens were expressed in edible plants, and [75] [76] [77] . These vaccines, defined as mucosal-targeted vaccines, bring about a prompt systematic and mucosal immune response. The functional site of mucosa-associated lymphoid tissues is associated with the gut, lungs and bronchial system. The secretory antibody IgA functions to prevent virus entry and (also) clumps antigens which are removed from the body in the mucus or feces. It is pertinent to mention that oral vaccine supposedly sustain activity in the intestine at acidic pH [78] . The tobacco (Nicotiana tabacum) plant has shown to be an efficient system for expressing different forms of antibodies, secretory IgG and IgA, single-chain variable fragments (scFvs), [79] , Fab fragments and bispecific antibodies. For example, monoclonal antibodies of an scFV against the West Nile virus have been made as a fusion protein in glycol-engineered N. benthamiana [80, 81] . Inoculation with full-length or deleted versions of RNA-2 comprising the heavy and light chains of a murine blood group-typing antibody fused with the C-terminus of the small CP domain via F2A resulted in the expression of assembled full-size IgG in N. bethamiana [82] . This approach has also been used to express derivatives of scFvs specific for TGEV in cowpea plants and the crude plant extracts supplied ad libitum to neonatal pigs to provide in vivo protection against challenge with this enteric pathogen [71] . Further, transient expression of antigenic epitopes of the rabies virus (RV) was also reported in tobacco, spinach and N. benthamiana, and successful immunization of mice was observed by feeding transgenic spinach [14] . Another interesting study reported the fusion of complementary DNAs of CT subunit B and A2 with the enterotoxin gene of rotavirus and enterotoxigenic fimbrial antigen gene of E. coli. This was transferred into potato, resulting in the expression of fusion antigens in transformed tissues.
These antigens were assembled into cholera holotoxin-like structures and exhibited affinity for enterocytes. Oral immunization into mice caused production of antibodies for pathogen antigens. Thus, it may be suggested that edible vaccine can provide simultaneous protection against viral and bacterial pathogens [83] .
There are reports about corn-based vaccines and gingerderived nanoparticles, including the use of plant glycans [84] [85] [86] . In one more study, transgenic tobacco leaves and potato tubers were established, which were capable of producing glutamic acid decarboxylase, a diabetes-associated antigen for treatment of Type II diabetes. The expression was detected at a level of 0.33 to 1.0 mg/g of fresh weight. Feeding 3 g transgenic plant tissue daily from 5 weeks to 8 months showed diabetes only in 2 of 12 mice [38] .
Alternative approaches for plant-derived antibodies
Chloroplast transformation for vaccine production Chloroplast transformation has been widely studied for the expression of a variety of compounds [87] and the cheap production of vaccines. Chloroplast genetic engineering offers several advantages over nuclear transformation: (as) there is increased biosafety related to release of integrated genes into the environment because of maternal inheritance of chloroplast genomes, multiple copies of chloroplast genome per cell enables high levels of protein expression, and possibility of co-expression of multiple genes provides a way to produce vaccines requiring multiple epitopes for activity and homologus recombination for transfer of transgene into chloroplast genome [88] [89] [90] [91] [92] . Chloroplast transformation also enables posttranslational changes in expressed proteins and correct folding required for antigenicity [93] . Further, foreign protein in the chloroplast does not interfere with growth and morphology of the host plant [91] .
Investigators have reported expression of many antigenic epitopes in this regard, including hepatitis, cervical cancer, AIDS and small pox. Other examples include Human Papillomavirus (HPV)-16 L1 VLPs epitope in tobacco [94] , Potato virus X (PVX) coat protein (CP) fused with HPV-16 E7 oncoprotein (E7-CP) in tobacco [95] , hepatitis E virus (HEV E2) in tobacco [96] , rotavirus (VP6) in tobacco [97] , HIV (p24-Nef) in tobacco and tomato [98] , CT-B fused with fibronectin-binding domain (D2) of S. aureus (CT-B-D2) in Chlamydomonas [99] and cholera toxin B-proinsulin fusion protein (CT-B-Pins) in tobacco and lettuce [100] . Though transplastomic expression of vaccine antigens is considered relatively safe compared to nuclear expression, these are also associated with polytropic effects [101] such as male sterility [102] and stunted growth of the host plant. Still, many other regulatory issues should be challenged such as degradation of proteins and efficacy of vaccines produced in chloroplast. In most of the cases, transplastomic study has been conducted in tobacco plants, and other species need to be explored [103] .
Genome editing
Genome editing techniques are associated with manipulating DNA at a specific location or repairing of existing DNA. For this purpose, commonly explored technologies are zinc-finger nucleases, clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein 9 and transcription activator-like effector nucleases [104, 105] . Recent development in genome editing techniques has enabled researchers to manipulate the genome at the sequence-specific level for a variety of purposes [105] [106] [107] . Genome editing has been used to engineer cell lines and organisms through gene knockout, deletion, correction, inversion [108] [109] [110] and chromosomal translocation [111] . Moreover, these sequence-specific nucleases have been effectively used for plant genetic engineering [112] : wheat [113] , soybean [114] , barley, Brassica oleracea [115] , tomato genome [116] and Arabidopsis [117] . Though genome editing may be caused by mutagenesis during cell culture, but such reports in the generation of transgenic plants for edible vaccines are limited. One example is the production of an edible vaccine against cedar pollen allergy in rice [118] where researchers have suggested cell culture steps as cause of mutation on the basis of whole-genome sequencing between transgenic line and host.
Epitope prediction for vaccine development using computational tools
Antibody epitope prediction is a crucial step of vaccine design. Various considerations such as hydrophilicity, flexibility, accessibility, turns, exposed surface, polarity and antigenic propensity of polypeptides chains have to be correlated with the location of continuous epitopes. Thus, epitope prediction is important when designing vaccines. System level understanding of cells with the help of in silico methods can also help in the prediction and localization of epitopes [15] . Still, these techniques are not used for design of antigen for plantibodies, but these methods are quick, accurate and can be helpful in plantibody manufacturing and may be vital in the biopharmaceutical industries (Table 4) . Moreover, Figure 4 also depicts the various bioinformaticsbased methods which can be used for epitope prediction. Some important methods are artificial neural network [136] [137] [138] , hidden Markov models, and molecular dynamics simulations [139] , structure activity relationships, support vector machines and virtual screening.
Common problems associated with plantibodies
There are certain important issues which need to be discussed for effectual plantibodies development. Some of them are explained in this section.
Immunomodulation
Immune-modulation has been used to study antigen/epitope function, as well as antigen mistargeting [140] . There are certain ways in which antibody affects protein: competitive and allosteric inhibition and interference in the protein folding. Antigen mistargeting in tobacco plants resulted in scFv fragment accumulation in the endoplasmic reticulum (ER) and binding of abscisic acid. TMV infection in tobacco plants resulted in the expression of a TMV virion-binding scFv fragment [141, 142] . Lessening of necrotic local lesion numbers was observed during virus infection as well as increased scFv targeting to the apoplast. In another study, camelid nanobodies have been recognized as an effective countermeasure against broad bean mottle virus (BBMV) infection. It was observed that these nanobodies controlled the growth of BBMV virus in Vicia faba [143] .
Development and commercialization issues
Although plants are being exploited successfully for expression of antigenic epitopes in the production of edible vaccines, there are still many challenges limiting their success. Despite the fact, many vaccines have completed Phase III of clinical trials [2] ; to date, no vaccine is available for market consumption [17] . Problems include improper gene transfer techniques; low levels of expression; difficulty in promoter identification, variation, codon biasing and scantly regulatory sites; inappropriate polyadenylation and unsuitable nuclear transport; mRNA instability and positional effects; epigenetic silencing; insufficient immune response after administration; regulatory issues and maintenance of Good Manufacturing Practice (GMP) standard [144] [145] [146] ; and selection of antigen and host [147] and consistency of dose [148] .
Conclusions and future prospects
The present review has demonstrated several examples of the production of recombinant proteins in plants, specifically vaccine production. Nevertheless, commercialization of PDAbs faces several limitations. Biosafety and environmental issues are affecting the promotion of bulk cultivation of engineered plants; however, existing regulatory norms are to be followed as per guidelines of the stakeholder's country. Researchers need to increase levels of antigen expression in plants along with targeted expression, but it needs a more focused approach. Nevertheless, there is a requirement for further comprehensive [135] studies of specific antigens before plant-based vaccines can be used as a product. Presently, United States Department of Agriculture (USDA) and Food and Drug Administration (FDA) regulate production of plant-derived vaccines. Although these regulatory bodies are controlling the production of these vaccines, we need to deliberate on the current insights on the evaluation of such products toward commercialization.
Key points
• Plant expression systems have several intrinsic advantages in terms of speed, costs, scalability and safety.
• Plant-based antigen expression has emerged as a viable technology for the production of recombinant proteins.
• To date, numerous antibodies are reported in a variety of different plant species.
• The success of PDAbs mainly depends on the development of transient and stable transformation for commonly grown crops and ease of cultivation.
